Your browser doesn't support javascript.
loading
Alliance Foundation Trial 09: A Randomized, Multicenter, Phase 2 Trial Evaluating Two Sequences of Pembrolizumab and Standard Platinum-Based Chemotherapy in Patients With Metastatic NSCLC.
Hensing, Thomas A; Wang, Xiaofei; Stinchcombe, Thomas E; Gao, Junheng; Knopp, Michael V; Watson, Mark; Dudek, Arkadiusz Z; Graziano, Stephen L; Patel, Jyoti D; Faller, Bryan A; Dragnev, Konstantin H; Kozono, David; Vokes, Everett E.
Afiliação
  • Hensing TA; NorthShore University Health System Kellogg Cancer Center, University of Chicago, Evanston, Illinois.
  • Wang X; Alliance Statistics and Data Center, Duke University, Durham, North Carolina.
  • Stinchcombe TE; Division of Medical Oncology, Duke Cancer Institute, Durham, North Carolina.
  • Gao J; Alliance Statistics and Data Center, Duke University, Durham, North Carolina.
  • Knopp MV; Department of Radiology, The Ohio State University Wexner Medical Center, Columbus, Ohio.
  • Watson M; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri.
  • Dudek AZ; HealthPartners Cancer Care Center, St. Paul, Minnesota.
  • Graziano SL; SUNY Upstate Medicine University, Syracuse, New York.
  • Patel JD; Lurie Cancer Center Northwestern University, Chicago, Illinois.
  • Faller BA; Missouri Baptist Medical Center, St. Louis, Missouri.
  • Dragnev KH; Dartmouth-Hitchcock Norris Cotton Cancer Center, Lebanon, New Hampshire.
  • Kozono D; Dana-Farber/Partners Cancer Care, Boston, Massachusetts.
  • Vokes EE; Section of Hematology/Oncology, Department of Medicine, University of Chicago Medical Center, Chicago, Illinois.
JTO Clin Res Rep ; 2(8): 100208, 2021 Aug.
Article em En | MEDLINE | ID: mdl-34590049

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2021 Tipo de documento: Article